[Campylobacter infection].
Ohnishi
Kenji
K
Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002169:Campylobacter Infections; D002168:Campylobacter fetus; D016123:Campylobacter jejuni; D015780:Carbapenems / Q000627:therapeutic use; D004696:Endocarditis / Q000382:microbiology; D005759:Gastroenteritis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D020275:Guillain-Barre Syndrome / Q000209:etiology; D006801:Humans; D018942:Macrolides; D016920:Meningitis, Bacterial / Q000382:microbiology; D019846:Miller Fisher Syndrome / Q000209:etiology; D011379:Prognosis; D018805:Sepsis / Q000382:microbiology; D015047:Zoonoses
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D018942:Macrolides